ARTICLE | Company News
AnGes, Morishita deal
May 28, 2012 7:00 AM UTC
AnGes said Morishita will use its enteric-coated capsule drug delivery technology with AnGes' HPV vaccine targeting E7 transforming protein (human papillomavirus-16; HpV16gp1). AnGes is developing the...